Abstract
A retrospective review was carried out of 34 consecutive traumatic spinal cord damaged patients who have had the Medtronics Programmable, Cordis Secor or Constant Infusion Infusaid intrathecal baclofen drug delivery systems inserted between July 1987 and 1992. The results indicate that whilst this treatment has many benefits there is a significant risk of complications, some potentially fatal. It should only be provided by a skilled and experienced team. The Medtronics Programmable pump is an excellent pump. It is of particular benefit where the therapeutic window is small or fine-tuning required. The Constant Infusion Infusaid is adequate if less precise control and continuous infusion is sufficient. It is of particular benefit in financially disadvantaged countries. The Cordis Secor device is helpful when unpredictable intermittent relief of spasticity is required but is otherwise limited by its complication rate.
Similar content being viewed by others
Article PDF
References
Penn R D, Kroin J S . Continuous intrathecal baclofen alleviates spinal cord spasticity. Lancet 1984; 1: 1078.
Broseta J et al. The use of intrathecal baclofen administered by programmable infusion pumps in persistent spasticity. Acta Chir Suppl Wien 1989; 46: 39-45.
Broseta J et al. Chronic intrathecal baclofen administration in severe spasticity. Stereotactic Funct Neurosurg 1990; 33: 147-153.
Hankey G J, Stewart-Wunne E G, Perlman D . Intrathecal baclofen for severe spasticity. Med J Aust 1986; 145: 465--466.
Latash M L, Penn R D, Corcos D M, Gottlieb G L . Effects of intrathecal baclofen on voluntary motor control in spastic paresis. J Neurosurg 1990; 72: 388-392.
Lazorthes Y . Chronic intrathecal administration of baclofen in treatment of severe spasticity. In: Muller H, Zierski J, Penn RD (eds) Local-spinal Therapy of Spasticity. Springer-Verlag: Berlin, Heidelberg, New York, London, Paris, Tokyo, 1988, pp 215-222.
Lazorthes Y, et al. Chronic intrathecal baclofen administration for control of severe spasticity. J Neurosurg 1990; 72: 393-402.
Loubser P G et al. Continuous infusion of intrathecal baclofen: long-term effects on spasticity in spinal cord injury. Paraplegia 1991; 29: 48-64.
Muller H et al. Intrathecal baclofen in spasticity. In: Muller H, Zierski J, Penn RD (eds). Local-spinal Therapy of Spasticity. Springer-Verlag: Berlin, Heidelberg, New York, London, Paris, Tokyo, 1988, pp 155-214.
Ochs G et al. Intrathecal baclofen for long-term treatment of spasticity: a multi-centre study. J Neurol Neurosurg Psychiatry 1989; 52: 933-939.
Penn R D, Kroin J S . Continuous intrathecal baclofen for severe spasticity. Lancet 1985; 11: 125-127.
Siegfried J, Rea G L . Intrathecal application of baclofen in the treatment of spasticity. Acta Neurochir Suppl Wien 1987; 39: 121-123.
Zierski J, Muller H, Dralle D, Wurdinger T . Implanted pump systems for treatment of spasticity. Acta Neurochir Suppl Wien 1988; 43: 94-99.
Talalla A, Grundy D, MacDonell R . The effect of intrathecal baclofen on the lower urinary tract in paraplegia. Paraplegia 1990; 28: 420-427.
Frost F, Nanninga J, Penn R, Savoy, Wu Y . Intrathecal baclofen infusion. Effect on bladder management programmes in patients with myelopathy. Am J Phys Med Rehabil 1989; 68: 112-115.
Nanninga J B, Frost F, Penn R . Effect of intrathecal baclofen on bladder and sphincter function. J Urol 1989; 142: 101-105.
Muller-Schwefe G, Penn R D . Physostigmine in the treatment of intrathecal baclofen overdose. Report of three cases. J Neurosurg 1989; 71: 273-275.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gardner, B., Jamous, A., Teddy, P. et al. Intrathecal baclofen–a multicentre clinical comparison of the Medtronics Programmable, Cordis Secor and Constant Infusion Infusaid drug delivery systems. Spinal Cord 33, 551–554 (1995). https://doi.org/10.1038/sc.1995.119
Issue Date:
DOI: https://doi.org/10.1038/sc.1995.119